-
The Importance of Myo Inositol Benefits In Women's Health
Myo inositol, as a natural polyol in human body, has attracted extensive attention in recent years.
2024-07-30 16:57 -
On the Synergies of 'Myo Inositol and D-Chiro Inositol' In Women's Health
In recent years, myo inositol and D-chiro inositol, two physiologically active substances, have gradually become the focus of research.
2024-07-30 16:56 -
To Explore the Application of 'Myo Inositol Powder' In Women's Health
In recent years,"myo inositol powder" has generated much discussion in the field of women's health.
2024-07-30 16:56 -
Women's Health From the Perspective of 'Myo Inositol PCOS'
"Myo inositol PCOS", a topic that has attracted much attention in the medical field in recent years, reveals the subtle relationship between endocrine...
2024-07-30 16:55 -
AbbVie's Immunology Division Generates $12.342 Billion in Revenue in H1 2024, Humira Declines by 32...
Recently, AbbVie officially unveiled its financial report for the first half of 2024.
2024-07-29 18:27 -
Merck's Breakthrough in RSV Antibody: Significant Reduction in Infant Respiratory Infections
Their prophylactic monoclonal antibody to Respiratory Syncytial Virus (RSV) clesrovimab (trade name MK-1654) achieved very positive results in phase 2...
2024-07-29 18:23 -
Brilliant Pharmaceutical Achieves New Success - Betamethasone Sodium Phosphate Injection Approved, 2...
According to statistics, since the beginning of the year, Bette Pharmaceutical and its subsidiaries have successfully passed the evaluation of the num...
2024-07-29 18:23 -
Sanofi's Bold Moves: Streamlining Pipeline, Terminating Research, Yet Delivering Robust 5.1% Growth
On July 25, Sanofi announced details of its latest round of pipeline adjustments and financial performance.
2024-07-29 18:21 -
EU Rejects Approval for Alzheimer's Drug Leqembi, Battering Stock of Developer Biogen
Alzheimer's disease, this profound neurodegenerative disease, undoubtedly casts a heavy shadow over the patients and their families.
2024-07-29 18:21 -
Semaglutide, the 'Weight Loss Wonder Drug', Approved for New Indications
Novo Nordisk is proud to announce that its weight loss drug Wegovy has been approved by the European Medicines Agency (EMA) for the prevention of stro...
2024-07-29 18:20
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
